SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
eXoZymes, Inc. (EXOZ) has a negative trailing P/E of -9.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -10.17%.
Criteria proven by this page:
- VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -9.8); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -10.17%).
- Trailing Earnings Yield -10.17% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
Overall SharesGrow Score: 33/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EXOZ
Valuation Multiples
P/E (TTM)-9.8
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio26.52
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.09
Book Value / Share$0.41
Revenue / Share$0.00
FCF / Share$-0.80
Yields & Fair Value
Earnings Yield-10.17%
Dividend Yield0.00%
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2021 |
-58.1 |
0.00 |
58.73 |
0.00 |
- |
| 2022 |
-50.4 |
-3.78 |
51.22 |
0.00 |
- |
| 2023 |
-34.5 |
-0.73 |
-182.93 |
0.00 |
- |
| 2024 |
-22.9 |
-0.12 |
12.87 |
0.00 |
- |
| 2025 |
-10.0 |
-0.19 |
26.89 |
0.00 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2021 |
$-0.15 |
$0.00 |
$-1.21M |
- |
| 2022 |
$-0.17 |
$0.00 |
$-1.4M |
- |
| 2023 |
$-0.25 |
$0.00 |
$-2.04M |
- |
| 2024 |
$0.00 |
$0.00 |
$-5.86M |
- |
| 2025 |
$-1.09 |
$0.00 |
$-9.16M |
- |
